PRFX

MKT CAP:$191666

PRF Technologies Ltd.

Market Cap

$191666

Healthcare·Drug Manufacturers - Specialty & Generic·🇮🇱 Israel·NASDAQ

Healthcare·Drug·🇮🇱·NASDAQ

Stock Price

$2.38-$1.11 (-31.76%)

Apr 23, 2026

Company Details

PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear ...

CEO

Ehud Geller

IPO Date

Sep 1, 2020

Website

prf-tech.com

Key Metrics TTM

Revenue

$0

— YoY

Net Income

-$4M

EPS (Diluted)

-$57.50

Free Cash Flow

-$6M

Revenue / Share

$0.00

Gross Margin

—

Operating Margin

—

Net Margin

—

FCF Margin

—

P/S

—

P/E

—

Earnings Reports

Q2 2025

Oct 1, 2025

$0EPS -$13.75

Q1 2025

Mar 31, 2025

$0EPS -$13.75

Q4 2024

Apr 7, 2025

$0EPS -$15.00

Q3 2024

Sep 30, 2024

$0EPS -$15.00

Q3 2023

Nov 15, 2023

$0EPS $19.80

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 20	$0	$0	-$132.0K
Q2 20	$0	$0	-$148.0K
Q3 20	$0	$0	-$700.0K
Q4 20	$0	$0	-$691.0K
Q1 21	$0	-$1.0K	-$2M
Q2 21	$0	-$1.0K	-$2M
Q3 21	$0	-$2.0K	-$2M
Q4 21	$0	-$3.0K	-$2M
Q1 22	$0	-$2.0K	-$2M
Q3 23	$0	-$3.0K	-$1M
Q3 24	$0	$0	-$881.5K
Q4 24	$0	$0	-$881.5K
Q1 25	$0	$0	-$1M
Q2 25	$0	$0	-$1M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 20	-$219.0K	-$219.0K
Q4 20	-$2M	-$2M
Q1 21	-$2M	-$2M
Q2 21	-$2M	-$2M
Q3 21	-$1M	-$1M
Q4 21	-$2M	-$2M
Q1 22	-$1M	-$1M
Q2 23	-$2M	-$2M
Q3 23	-$1M	-$1M
Q4 23	-$1M	-$1M
Q1 24	-$4M	-$4M
Q2 24	-$5M	-$5M
Q3 24	-$2M	-$2M
Q4 24	-$2M	-$2M
Q1 25	-$991.0K	-$991.0K
Q2 25	-$991.0K	-$991.0K

Capital Expenditures

Quarter	CapEx
Q3 20	$0
Q4 20	$10.0K
Q1 21	$13.0K
Q2 21	$3.0K
Q3 21	$6.0K
Q4 21	$28.0K
Q1 22	$0
Q2 23	$0
Q3 23	$8.0K
Q4 23	$936
Q1 24	$7.0K
Q2 24	$5.0K
Q3 24	$500
Q4 24	$500
Q1 25	$0
Q2 25	$0

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 21	—	+1444.7%
Q2 21	—	+1021.6%
Q3 21	—	+152.6%
Q4 21	—	+152.0%
Q1 22	—	-18.0%
Q3 23	—	-18.6%
Q3 24	—	-50.1%
Q4 24	—	-49.4%
Q1 25	—	-29.2%
Q2 25	—	-12.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 20	$6.0K	—
Q4 20	$6.0K	—
Q1 21	$164.0K	—
Q2 21	$203.0K	—
Q3 21	$215.0K	—
Q4 21	$230.0K	—
Q1 22	$210.0K	—
Q2 23	$261.0K	—
Q3 23	$182.0K	—
Q4 23	$181.0K	—
Q1 24	$115.0K	—
Q2 24	$83.0K	—
Q3 24	$56.0K	—
Q4 24	$56.0K	—
Q1 25	$0	—
Q2 25	$0	—

OpEx Breakdown

Quarter	R&D	G&A
Q1 20	$24.0K	$108.0K
Q2 20	$41.0K	$107.0K
Q3 20	$27.0K	$673.0K
Q4 20	$262.0K	$429.0K
Q1 21	$1M	$1M
Q2 21	$702.0K	$958.0K
Q3 21	$573.0K	$1M
Q4 21	$556.0K	$1M
Q1 22	$680.0K	$992.0K
Q3 23	$589.0K	$763.0K
Q3 24	$149.0K	$732.5K
Q4 24	$149.0K	$732.5K
Q1 25	$139.0K	$958.5K
Q2 25	$139.0K	$958.5K

War Chest

Quarter	Cash	Short-term Investments	Total
Q3 18	$40.0K	$0	$40.0K
Q4 18	$40.0K	$0	$40.0K
Q1 19	$88.0K	$0	$88.0K
Q2 19	$88.0K	$0	$88.0K
Q3 19	$941.0K	$0	$941.0K
Q4 19	$941.0K	$0	$941.0K
Q1 20	$0	$2M	$2M
Q2 20	$544.0K	$0	$544.0K
Q4 22	$4M	$0	$4M
Q1 24	$4M	$0	$4M
Q2 24	$3M	$0	$3M
Q3 24	$4M	$0	$4M
Q4 24	$4M	$0	$4M
Q1 25	$3M	$0	$3M
Q2 25	$3M	$0	$3M
Q4 25	$3M	$1M	$4M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 20	1K	—	—
Q2 20	1K	0.0%	—
Q3 20	1K	-0.2%	—
Q4 20	1K	-1.7%	—
Q1 21	2K	+3.4%	+1.4%
Q2 21	2K	+11.1%	+12.7%
Q3 21	2K	+0.5%	+13.5%
Q4 21	2K	+3.7%	+19.7%
Q1 22	2K	0.0%	+15.8%
Q3 23	2K	+4.0%	+8.3%
Q3 24	59K	+3139.2%	+3392.9%
Q4 24	59K	0.0%	+3269.0%
Q1 25	85K	+44.3%	+4762.2%
Q2 25	85K	0.0%	+4574.8%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 20	—	—
Q2 20	—	—
Q3 20	—	—
Q4 20	$0	10
Q1 21	$0	10
Q2 21	$0	10
Q3 21	$0	10
Q4 21	$0	4
Q1 22	$0	4
Q3 23	$0	6
Q3 24	$0	7
Q4 24	$0	6
Q1 25	$0	6
Q2 25	$0	6

Revenue / Employee